Literature DB >> 24452334

Glycogen accumulation underlies neurodegeneration and autophagy impairment in Lafora disease.

Jordi Duran1, Agnès Gruart2, Mar García-Rocha3, José M Delgado-García2, Joan J Guinovart4.   

Abstract

Lafora disease is a fatal neurodegenerative condition characterized by the accumulation of abnormal glycogen inclusions known as Lafora bodies. It is an autosomal recessive disorder caused by mutations in either the laforin or malin gene. To study whether glycogen is primarily responsible for the neurodegeneration in Lafora disease, we generated malin knockout mice with impaired (totally or partially) glycogen synthesis. These animals did not show the increase in markers of neurodegeneration, the impairments in electrophysiological properties of hippocampal synapses, nor the susceptibility to kainate-induced epilepsy seen in the malin knockout model. Interestingly, the autophagy impairment that has been described in malin knockout animals was also rescued in this double knockout model. Conversely, two other mouse models in which glycogen is over-accumulated in the brain independently of the lack of malin showed impairment in autophagy. Our findings reveal that glycogen accumulation accounts for the neurodegeneration and functional consequences seen in the malin knockout model, as well as the impaired autophagy. These results identify the regulation of glycogen synthesis as a key target for the treatment of Lafora disease.
© The Author 2014. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24452334     DOI: 10.1093/hmg/ddu024

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  79 in total

Review 1.  Glycogen phosphorylation and Lafora disease.

Authors:  Peter J Roach
Journal:  Mol Aspects Med       Date:  2015-08-13

2.  Glycogen: the missing link in neuronal autophagy?

Authors:  Akanksha Onkar; Deepashree Sheshadri; Subramaniam Ganesh
Journal:  Autophagy       Date:  2020-08-02       Impact factor: 16.016

3.  Targeting Pathogenic Lafora Bodies in Lafora Disease Using an Antibody-Enzyme Fusion.

Authors:  M Kathryn Brewer; Annette Uittenbogaard; Grant L Austin; Dyann M Segvich; Anna DePaoli-Roach; Peter J Roach; John J McCarthy; Zoe R Simmons; Jason A Brandon; Zhengqiu Zhou; Jill Zeller; Lyndsay E A Young; Ramon C Sun; James R Pauly; Nadine M Aziz; Bradley L Hodges; Tracy R McKnight; Dustin D Armstrong; Matthew S Gentry
Journal:  Cell Metab       Date:  2019-07-25       Impact factor: 27.287

4.  Central Nervous System Delivery and Biodistribution Analysis of an Antibody-Enzyme Fusion for the Treatment of Lafora Disease.

Authors:  Grant L Austin; Zoe R Simmons; Jack E Klier; Alberto Rondon; Brad L Hodges; Robert Shaffer; Nadine M Aziz; Tracy R McKnight; James R Pauly; Dustin D Armstrong; Craig W Vander Kooi; Matthew S Gentry
Journal:  Mol Pharm       Date:  2019-08-02       Impact factor: 4.939

5.  Modulators of Neuroinflammation Have a Beneficial Effect in a Lafora Disease Mouse Model.

Authors:  Belén Mollá; Miguel Heredia; Pascual Sanz
Journal:  Mol Neurobiol       Date:  2021-01-14       Impact factor: 5.590

Review 6.  [Lafora disease: a review of the literature].

Authors:  L Desdentado; R Espert; P Sanz; J Tirapu-Ustarroz
Journal:  Rev Neurol       Date:  2019-01-16       Impact factor: 0.870

7.  Astrocytes and neurons produce distinct types of polyglucosan bodies in Lafora disease.

Authors:  Elisabet Augé; Carme Pelegrí; Gemma Manich; Itsaso Cabezón; Joan J Guinovart; Jordi Duran; Jordi Vilaplana
Journal:  Glia       Date:  2018-08-26       Impact factor: 7.452

8.  An Isozyme-specific Redox Switch in Human Brain Glycogen Phosphorylase Modulates Its Allosteric Activation by AMP.

Authors:  Cécile Mathieu; Romain Duval; Angélique Cocaign; Emile Petit; Linh-Chi Bui; Iman Haddad; Joelle Vinh; Catherine Etchebest; Jean-Marie Dupret; Fernando Rodrigues-Lima
Journal:  J Biol Chem       Date:  2016-09-22       Impact factor: 5.157

9.  Molecular Mechanisms of Allosteric Inhibition of Brain Glycogen Phosphorylase by Neurotoxic Dithiocarbamate Chemicals.

Authors:  Cécile Mathieu; Linh-Chi Bui; Emile Petit; Iman Haddad; Onnik Agbulut; Joelle Vinh; Jean-Marie Dupret; Fernando Rodrigues-Lima
Journal:  J Biol Chem       Date:  2016-12-13       Impact factor: 5.157

Review 10.  Lafora disease - from pathogenesis to treatment strategies.

Authors:  Felix Nitschke; Saija J Ahonen; Silvia Nitschke; Sharmistha Mitra; Berge A Minassian
Journal:  Nat Rev Neurol       Date:  2018-10       Impact factor: 42.937

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.